• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bal Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4704.0
  • ISIN : INE083D01012
83.90 -1 (-0.67%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    82.57

  • Today’s High

    87.62

  • Open

    83.80

  • Perv Close

    84.47

  • 52W Low

    78.06

  • 52W High

    157.98

Key Indicators

  • P/E(TTM)

    12.81

  • Mar.Cap (₹Cr.)

    133.58

  • Div & Yield %

    1.43

  • Book Value(₹)

    67.04

  • Debt-Equity Ratio

    -0.67

  • AGM Date

    28-Mar-2025

  • EPS

    6.49

  • P/E Ratio

    12.81

Financials Ratios

  • Debt-Equity Ratio

    2.03

  • Mar.Cap (₹Cr.)

    133.58

  • RONW (%)

    11.20

  • ROCE (%)

    11.74

Score Board

  • Equity (₹ in Cr.)

    15.92

  • BV (₹)

    67.00

  • Sales( ₹ in Cr.)

    338.54

  • NP (in Cr.)

    10.23

  • NP Var(%)

    68.0

  • Div%

    12.0

  • CPS (₹)

    11.70

  • EPS (₹)

    6.40

  • Traded Value (₹ in Lakhs)

    132.40

  • 52 Week High

    157.98

  • 52 Week Low

    78.06

  • Price BSE

    83.0

  • Price NSE

    84.00

  • Market Capital( in Cr.)

    132.40

  • P/C Ratio

    7.10

  • P/E Ratio

    12.90

  • Price Vs.BV

    6.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 338.54 303.10 280.37 249.31 170.67 223.08
Excise Duty 325.67 300.63 278.85 245.74 166.70 218.53
Net Sales 338.54 303.10 280.37 249.31 170.67 223.08
Other Income 3.35 2.19 6.49 2.69 3.63 2.75
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 341.89 305.29 286.86 252.00 174.30 225.83
EXPENDITURE :
Raw Materials 325.67 300.63 278.85 245.74 166.70 218.53
Power & Fuel Cost 325.67 300.63 278.85 245.74 166.70 218.53
Employee Cost 56.11 51.56 44.46 39.62 48.78 48.45
Other Manufacturing Expenses 1.69 2.03 4.56 3.53 0.96 0.77
Selling & Administrative Expenses 30.93 26.21 21.64 15.44 17.59 23.05
Miscellaneous Expenses 1.69 2.03 4.56 3.53 0.96 0.77
Less : Pre-operative Expenses Capitalised :
Total Expenditure 329.79 296.74 274.80 242.20 183.38 221.41
Operating Profit 25.64 27.07 20.01 13.82 11.75 13.57
Interest 15.24 12.46 10.40 11.96 12.55 12.53
Gross Profit 12.11 8.55 12.06 9.80 -9.08 4.41
Depreciation 8.45 7.48 7.24 7.26 7.03 6.12
Profit Before Tax 12.11 8.55 12.06 9.80 -9.08 4.41
Tax 3.20 2.58 4.48 0.38 0.00 1.03
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.08 0.39 -1.94 0.32 -0.03 -3.30
Reported Net Profit 10.27 6.13 8.58 9.10 -8.90 6.76
Extraordinary Items 12.11 8.55 12.06 9.80 -9.08 4.41
Adjusted Net Profit 10.27 6.13 8.58 9.10 -8.90 6.76
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 1.90 1.57 1.48 1.48 0.00 1.42
P & L Balance carried down 10.27 6.13 8.58 9.10 -8.90 6.76
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 12.00 10.00 10.00 10.00 0.00 10.00
Dividend Per Share(Rs) 1.20 1.00 1.00 1.00 0.00 1.00
Earnings Per Share-Unit Curr 6.72 3.90 5.79 6.41 -6.28 4.77
Book Value 1.90 1.57 1.48 1.48 0.00 1.42
Book Value(Adj)-Unit Curr 1.90 1.57 1.48 1.48 0.00 1.42

Shareholding Pattern

  • Promoter Group

    50.86%

  • Public Share Holding

    49.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 655,187 655,187.00 655,187 655,187
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 655,187 4.12 655,187 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,011,736 12.64 2,011,736 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,430,259 34.11 5,430,259 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,441,995 46.74 7,441,995 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 21,822 0.14 21,822 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 21,822 0.14 21,822 3
2] Non Institution
Bodies Corporate 130,018 0.82 129,517 68
Clearing Members 570 0.00 570 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,982,376 12.45 1,972,876 173
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 368,114 2.31 368,114 274
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,461,421 9.18 1,461,421 22
Individuals holding nominal share capital up to Rs. 1 lakh 3,724,459 23.39 3,627,992 15,105
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 124,770 0.78 124,770 1
Sub Total 7,801,868 49.00 7,695,400 15,653
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 15,920,872 100.00 15,814,404 15,667

Company Background

Bal Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Bal Pharma Ltd
  • BSE Code : 4704.0
  • ISIN : INE083D01012

  • Incorporation Year

    1987

  • Registered Office

    21 & 22 Bommasandra Indl Area
    Hosur Road, Bangalore,
    Karnataka-560092

  • Telephone

  • FAX

  • Chairman

  • Managing Director

    Shailesh Siroya

  • Company Secretary

    Abdul Basith

  • Auditor

    SSJNB & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    TSR Consultants P Ltd
    C-101 1st Floor,
    247 Park Vikhroli W,Lal Bahadur Marg
    Mumbai - Mumbai - 400 083

Bal Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bal Pharma 83.16 341.89 338.54 12.81 11.63
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92